.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
McKinsey
Fish and Richardson
Accenture
Daiichi Sankyo
Mallinckrodt
Cipla
Citi
Cantor Fitzgerald
Harvard Business School

Generated: September 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204760

« Back to Dashboard
NDA 204760 describes MOVANTIK, which is a drug marketed by Astrazeneca Pharms and is included in one NDA. It is available from three suppliers. There are six patents protecting this drug. Additional details are available on the MOVANTIK profile page.

The generic ingredient in MOVANTIK is naloxegol oxalate. Three suppliers are listed for this compound. Additional details are available on the naloxegol oxalate profile page.

Summary for NDA: 204760

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:6
Formulation / Manufacturing:see details

Pharmacology for NDA: 204760

Mechanism of ActionOpioid Antagonists

Suppliers and Packaging for NDA: 204760

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MOVANTIK
naloxegol oxalate
TABLET;ORAL 204760 NDA AstraZeneca Pharmaceuticals LP 0310-1969 0310-1969-30 30 TABLET, FILM COATED in 1 BOTTLE (0310-1969-30)
MOVANTIK
naloxegol oxalate
TABLET;ORAL 204760 NDA AstraZeneca Pharmaceuticals LP 0310-1969 0310-1969-39 10 BLISTER PACK in 1 CARTON (0310-1969-39) > 10 TABLET, FILM COATED in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 12.5MG BASE
Approval Date:Sep 16, 2014TE:RLD:Yes
Regulatory Exclusivity Expiration:Sep 16, 2019
Regulatory Exclusivity Use:NEW CHEMICAL ENTITY
Patent:► SubscribePatent Expiration:Jun 29, 2024Product Flag?YSubstance Flag?Delist Request?
Patented Use:TREATMENT OF OPIOID-INDUCED CONSTIPATION
Patent:► SubscribePatent Expiration:Oct 18, 2022Product Flag?YSubstance Flag?YDelist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Moodys
Covington
Express Scripts
Chubb
QuintilesIMS
Dow
AstraZeneca
Boehringer Ingelheim
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot